DEPTOR and neoplasm: In patient group 2, the gene DEPTOR, which is known to inhibit lung tumorigenesis [40], is negatively correlated with tumor variance (Supplementary Figure S4, red samples), suggesting its potential role as a diagnostic biomarker for differentiating patients at high risk of progression.